1. What Is the Phage Therapy Market?
The Phage Therapy Market covers therapeutic bacteriophage preparations, personalized phage cocktail manufacturing, phage library biobank services, and clinical-grade phage production facilities. These products use viruses that selectively infect and kill targeted bacterial pathogens. Core applications include compassionate use treatment of pan-drug-resistant MDR bacterial infections, wound infection biofilm eradication, prosthetic joint infection treatment, and anti-biofilm phage coatings. Market dynamics reflect growing MDR infection unmet need, FDA expanded access compassionate use programs, and early-stage clinical trial phage therapy evidence accumulation. Personalized phage cocktail manufacturing and phage biobank infrastructure are primary capability investments.
2. Phage Therapy Market Size & Forecast
3. Emerging Technologies
- Synthetic biology-engineered phages with expanded host range and reduced lysogen formation are advancing. Growing development is driven by natural phage host range limitations for some drug-resistant pathogens.
- GMP phage manufacturing scale-up processes enabling clinical trial supply are advancing. Growing investment is driven by the lack of established pharmaceutical phage manufacturing frameworks.
- Phage therapy regulatory pathway development with FDA and EMA for phage personalized medicine are advancing. Growing regulatory engagement is driven by need for bespoke phage therapy approval frameworks.
- Phage-coated orthopedic implant surfaces preventing prosthetic joint infection are advancing. Growing development is driven by prosthetic joint infection prevention as an alternative to systemic therapy.
Such innovations are driving change across adjacent industries too. Discover more in our Antimicrobial Resistance Market.
4. Key Market Opportunity
The primary opportunity in the Phage Therapy Market is compassionate use MDR infection treatment services. Phage biobank infrastructure creates a platform capability and service revenue opportunity. Phage-antibiotic combination clinical trials create a pharmaceutical development partnership market. Asia Pacific phage therapy market growth in Georgia, Poland, and China creates geographic opportunity.
5. Top Companies in the Phage Therapy Market
The following organisations hold leading positions in the Phage Therapy Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Adaptive Phage Therapeutics
- Pherecydes Pharma
- PHAGOBIOTIC Foundation
- Armata Pharmaceuticals
- BiomX
- Intralytix
- Locus Biosciences
- Nextbiotics
- Felix Biotechnology
- UC San Diego IPATH (research center)
6. Market Segmentation
The Phage Therapy Market is analysed across 4 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Type | Therapeutic Phage Cocktails Personalized Phage Preparations Phage-Antibiotic Combined Effect Combos |
| By Application | MDR Wound Infections Prosthetic Joint Infections Bacteremia Anti-Biofilm Therapy |
| By End User | Hospitals Compassionate Use Programs Clinical Trials Phage Therapy Centers |
| By Geography | North America Europe Asia Pacific Latin America Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Phage Therapy Market trajectory over the forecast period:
Compassionate Use Phage Therapy Cases Are Building Clinical Evidence for MDR Infection Treatment.Published compassionate use case series report phage therapy responses in pan-drug-resistant Staphylococcus and Pseudomonas. UC San Diego's Center for Innovative Phage Applications and Therapeutics has the largest compassionate case series. Each successful case adds to the clinical evidence portfolio supporting phage therapy clinical trial design. Compassionate use evidence is the primary near-term driver for phage therapy program development.
Phage-Antibiotic Combined Effect Combinations Are Demonstrating Enhanced Bactericidal Activity in Biofilm Models.Phages combined with antibiotics achieve combined killing in in-vitro and murine infection models. Biofilm penetration by phages exposes bacteria to antibiotic concentrations previously blocked by biofilm barriers. Phage-antibiotic combination clinical programs are advancing in diabetic foot and prosthetic joint infections. Combined Effect combinations are the leading clinical development approach for phage therapy entry into phase 2.
Phage Library Biobank Infrastructure Is Advancing Rapid Matched Phage Identification for Patients.Biobanks holding 1,000-plus characterized phages enable rapid matching to individual patient bacterial isolates. Rapid phage matching reduces time to compassionate use phage therapy from months to days. Adaptive Phage Therapeutics, PHAGOBIOTIC, and Pherecydes Pharma are building commercial phage biobank capabilities. Biobank infrastructure investment is a prerequisite for scaling compassionate use phage therapy programs.
For related market intelligence, see the Bacteriophage Market.
8. Segmental Analysis
By type, the Compassionate Use Personalized Phage Preparation segment dominated the Phage Therapy Market in 2025. Individualized matched phage preparations are the most clinically advanced phage therapy approach available. The Engineered Synthetic Phage segment is fastest-growing, driven by host range expansion and improved potency.
9. Regional Analysis
Regional demand patterns across the Phage Therapy Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America dominated the Phage Therapy Market in 2025 with a market share of 43.0%. The region hosts the most advanced phage therapy clinical research programs at UC San Diego and Yale. FDA expanded access compassionate use phage approvals create regulatory precedent for US market development. Moreover, US biotech companies including Armata and BiomX are advancing phage therapy clinical trials. Clinical research leadership and regulatory engagement sustain North American market dominance.
Highest CAGR Region
Asia Pacific is projected to register the highest CAGR of 29.68% in the Phage Therapy Market through 2034. Georgia and Poland have the longest historical tradition of therapeutic phage use outside antibiotics. China's pharmaceutical innovation programs are funding phage therapy bacteriophage development programs. Moreover, Australia and Japan are establishing phage therapy compassionate use regulatory pathways. Historical phage tradition and innovation investment position Asia Pacific for sustained outperformance.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology adoption trends and innovation tracking
- • Custom company profiling and benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country Trade Analysis
- • Country-level opportunity mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • List of Raw Material Suppliers
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Phage Therapy Market was valued at USD 600.00 Mn in 2025 and is projected to reach USD 3,385.90 Mn by 2034, growing at a CAGR of 21.20% over the 2026–2034 forecast period.
The Phage Therapy Market is projected to grow at a CAGR of 21.20% from 2026 to 2034.
North America dominated the Phage Therapy Market in 2025 with a market share of 43.0%.
The leading companies in the Phage Therapy Market include Adaptive Phage Therapeutics, Pherecydes Pharma, PHAGOBIOTIC Foundation, Armata Pharmaceuticals, BiomX, Intralytix, Locus Biosciences, Nextbiotics, Felix Biotechnology, UC San Diego IPATH (research center).
Compassionate use phage therapy cases are building clinical evidence for mdr infection treatment.
By type, the Compassionate Use Personalized Phage Preparation segment dominated the Phage Therapy Market in 2025.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.